Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

    NEXT STORY
    Global Sports Medicine Markets to 2024 – An $8.8 Billion Opportunity, Rising at a CAGR of 6%
    PREV STORY
    Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    FDS Introduces New Comprehensive Medical Billing Solution, Provides New Revenue Opportunities for Community Pharmacies

    author_avatar
    NASDAQ Market News

    Genocea Biosciences Provides Clinical Update

    author_avatar
    NASDAQ Market News

    Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus

    author_avatar
    NASDAQ Market News